Derris

Derris elliptica roots contain rotenone and related isoflavonoids (deguelin, elliptone, tephrosin) that inhibit mitochondrial Complex I of the electron transport chain, disrupting ATP synthesis in target organisms. Preclinical evidence is limited to insect bioassays and a single rat study where methanolic leaf extract at 400 mg/kg reduced blood glucose from 44.02 to 16.83 mmol/L, comparable to glibenclamide, though no human clinical data exist.

Origin & History

Derris elliptica is native to Southeast Asia and the Pacific Islands, with a distribution spanning Malaysia, Indonesia, the Philippines, and Micronesia, where it thrives in tropical lowland forests and riverbanks with high humidity. The woody climbing legume is traditionally cultivated or wild-harvested, with its roots prized for their exceptionally high rotenone content, which varies by soil composition and growing conditions. Pacific Island communities, particularly in Micronesia and Melanesia, have historically integrated the plant into subsistence practices along waterways and agricultural plots.

Historical & Cultural Context

Derris elliptica has occupied a prominent place in the traditional ecological knowledge of Micronesian, Melanesian, and Southeast Asian communities for centuries, where the root—commonly called 'tuba' in Filipino and Pacific Island traditions—was crushed and introduced into rivers and tidal pools to temporarily stun fish, enabling easy collection without nets or traps, a practice documented across the Pacific and maritime Southeast Asia. The plant's potency as a piscicide and insecticide was recognized long before formal chemical characterization, and Dutch and British colonial botanists in the 19th and early 20th centuries catalogued its use across Java, Borneo, and the Philippines, eventually leading to rotenone's industrial development as a 'natural' insecticide and acaricide in Western agriculture. Medicinal uses, including topical application for skin parasites and ectoparasite control in livestock, are noted in regional ethnobotanical surveys from Micronesia and Borneo, though these applications remain poorly documented and have not been systematically studied. The plant's dual identity as both a traditional community resource and an agricultural chemical precursor reflects the complex boundary between ethnobotanical heritage and industrial exploitation that characterizes many Pacific Island plant species.

Health Benefits

- **Antiparasitic and Pesticidal Activity**: Rotenone and deguelin in the root extract achieve larvicidal LC50 of 1,600 ppm and LC90 of 2,040 ppm against Aedes aegypti larvae, with 100% mortality at highest concentrations after 24 hours, supporting traditional use as a natural parasite-control agent.
- **Potential Antidiabetic Effects**: Methanolic leaf extract (DEME) at 200–400 mg/kg reduced fasting blood glucose in diabetic Sprague-Dawley rats from 44.02 ± 5.19 to 16.83 ± 3.14 mmol/L, suggesting glucose-lowering properties though mechanisms remain incompletely characterized.
- **Hepatoprotective Indicators**: The same preclinical rat study demonstrated normalization of liver enzymes, with ALT reduced to 61.17 ± 6.9 U/L in treated animals, indicating a potential protective effect on hepatic tissue under metabolic stress conditions.
- **Antioxidant Properties**: Flavonoids isolated from Derris elliptica, including apigenin, luteolin, and formononetin, exhibit antioxidant activity in vitro comparable to ascorbic acid and butylated hydroxytoluene (BHT), suggesting free-radical scavenging capacity in leaf and root fractions.
- **Natural Piscicide and Traditional Aquatic Parasite Control**: Crushed root extracts applied at 10 g/L have been used in Micronesian and Southeast Asian traditions to stun or kill fish and aquatic parasites, with 90% documented efficacy against brown planthoppers in agricultural settings.
- **Protease Inhibition**: An isolated alkaloid from methanol root extracts, characterized by tertiary amine C-N groups (IR: 1300–1476 cm⁻¹), demonstrated 100% mortality against Scotinophara coartata at 0.1% concentration via protease inhibitory activity, suggesting a distinct non-rotenone mechanism.
- **Anti-inflammatory Potential**: Phenolic compounds including formononetin and luteolin present in the root and leaf are recognized in broader botanical literature as modulators of pro-inflammatory pathways, though no Derris-specific anti-inflammatory trials have been conducted.

How It Works

Rotenone, the dominant isoflavonoid in Derris elliptica roots, acts as a high-affinity inhibitor of NADH-ubiquinone oxidoreductase (Complex I) in the mitochondrial electron transport chain, blocking electron transfer and thereby suppressing ATP synthesis, leading to cellular energy depletion and death in susceptible organisms including insects, larvae, and fish. Deguelin and tephrosin function through structurally analogous mechanisms, reinforcing Complex I inhibition and potentially contributing to downstream reactive oxygen species (ROS) generation that amplifies cytotoxic effects. A separately isolated alkaloid fraction exerts protease inhibitory activity, interfering with digestive enzyme function in target insects, representing a mechanistically distinct pathway from rotenone's mitochondrial action. In the antidiabetic preclinical context, the methanolic leaf extract's glucose-lowering and liver enzyme normalization effects suggest possible modulation of hepatic gluconeogenesis or pancreatic insulin secretion, though the specific molecular targets—such as alpha-glucosidase, GLUT transporters, or PPAR-gamma—have not been formally identified in published studies.

Scientific Research

The available body of research on Derris elliptica is exclusively preclinical, comprising in vitro pesticidal bioassays, insect field trials, and a single animal pharmacology study; no human clinical trials, randomized controlled trials, or systematic reviews have been published. Larvicidal studies document quantified LC50 (1,600 ppm) and LC90 (2,040 ppm) values for methanolic root extract against Aedes aegypti, with statistically measurable mortality gradients across concentration ranges, though sample sizes for insect cohorts are typically not reported in standard epidemiological terms. The sole mammalian study used streptozotocin-induced diabetic Sprague-Dawley rats and reported statistically significant glucose reduction at 400 mg/kg (p<0.05 vs. diabetic controls), but the study lacked blinding details, power calculations, and long-term follow-up, substantially limiting interpretive confidence. Overall, the evidence base is rated preliminary, sufficient to justify further mechanistic and safety research but wholly insufficient to support human therapeutic recommendations.

Clinical Summary

No human clinical trials have been conducted on Derris elliptica for any indication, including its traditional use in parasite control or any explored medicinal application such as diabetes management. The most structured preclinical data comes from a rat model of streptozotocin-induced diabetes in which methanolic leaf extract at 200–400 mg/kg produced dose-dependent blood glucose reduction (best result: 16.83 ± 3.14 mmol/L vs. 44.02 ± 5.19 in diabetic controls) and ALT normalization (61.17 ± 6.9 U/L), with outcomes statistically comparable to the reference drug glibenclamide. Effect sizes (Cohen's d) were not reported, and the study's methodological limitations—including unspecified sample sizes, absence of pharmacokinetic data, and single-laboratory origin—severely constrain translational confidence. Insect and larvicidal trials provide reproducible quantitative endpoints but are not relevant to human health outcomes, leaving the clinical evidence landscape for Derris elliptica essentially undeveloped.

Nutritional Profile

Derris elliptica is not characterized as a food or nutritional source, and no established macronutrient or micronutrient profile exists in the scientific literature. The root's bioactive constituents are dominated by isoflavonoid rotenoids: rotenone (the most abundant, comprising up to several percent of dry root weight in high-yield varieties), deguelin, elliptone, toxicarol, tephrosin, and sumatrol. Secondary phytochemicals include flavones (apigenin, luteolin), an isoflavone (formononetin), and cumaronchromone derivatives (6,4'-dihydroxy-7,5-dimethoxy and 7,4'-dihydroxy-5'-methoxy variants), as well as alkaloids isolated from methanol fractions. Bioavailability data for any of these compounds in human digestive physiology are entirely absent, and given rotenone's known toxicity profile, the root is not considered a source of beneficial nutritional phytochemicals for human dietary intake.

Preparation & Dosage

- **Traditional Crude Root Extract (Aquatic Use)**: Roots crushed and steeped in water at approximately 10 g per liter; used externally or applied to waterways for fish stunning and parasite control in Pacific Island traditions—not for internal human consumption.
- **Methanolic Root Extract (Research Use Only)**: Prepared via methanol maceration and chromatographic purification (chloroform:methanol 8:2 mobile phase); concentrations of 0.01–0.1% used in pesticidal bioassays; no human-applicable dose established.
- **Methanolic Leaf Extract—Antidiabetic Research Context**: Administered at 200–400 mg/kg body weight in rat models; direct extrapolation to human dosing is not scientifically valid and has not been attempted in any published protocol.
- **No Standardized Supplement Form**: Derris elliptica is not commercially available as a standardized dietary supplement; no capsule, tablet, tincture, or standardized extract product has an established dose, concentration specification, or regulatory approval for human use.
- **Timing and Duration**: No timing or duration data exist for medicinal use; all studied preparations are experimental or traditional-agricultural in context.

Synergy & Pairings

No formally studied synergistic ingredient combinations exist for Derris elliptica in the context of human health applications. In agricultural and biopesticidal contexts, rotenone-containing Derris extracts have historically been combined with pyrethrin-containing plant extracts (e.g., Chrysanthemum cinerariifolium) to achieve broader-spectrum insecticidal activity through complementary mechanisms—rotenone disrupting mitochondrial ATP synthesis while pyrethrins target voltage-gated sodium channels in insect neurons. Any consideration of synergistic medicinal stacking is entirely speculative given the absence of human safety and efficacy data.

Safety & Interactions

Rotenone, the principal bioactive compound in Derris elliptica, is a well-documented neurotoxin in animal models associated with Parkinson's disease-like dopaminergic neurodegeneration in the substantia nigra; systemic exposure in humans carries serious neurotoxicity risk, and the compound has been restricted or banned in multiple jurisdictions as a pesticide due to environmental and mammalian toxicity concerns. No specific drug interaction data exist for Derris elliptica extracts in humans, but rotenone's mechanism as a mitochondrial Complex I inhibitor suggests theoretical additive toxicity with other mitochondria-affecting agents including metformin, statins, and certain antiretrovirals. Derris elliptica root preparations are contraindicated for internal human consumption in any form; the plant is not safe for use during pregnancy or lactation given its potent cellular toxicity, and no maximum safe dose for human medicinal use has been established. The preclinical rat antidiabetic study reported no overt hepatotoxicity at tested doses and showed enzyme normalization, but this single study using leaf extract cannot be extrapolated to root preparations or to human safety conclusions.